Total Payments
$734.32
2024 Payments
$117.97
Companies
14
Transactions
40
Medicare Patients
2,030
Medicare Billing
$208,800
Payment Breakdown by Category
Food & Beverage$734.32 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $734.32 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $262.32 | 15 | $0 (2019) |
| Smith+Nephew, Inc. | $95.11 | 4 | $0 (2024) |
| Novo Nordisk Inc | $82.95 | 5 | $0 (2021) |
| Amgen Inc. | $59.48 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $45.27 | 2 | $0 (2017) |
| TREACE MEDICAL CONCEPTS, INC. | $41.91 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $30.51 | 2 | $0 (2017) |
| Nevro Corp. | $22.12 | 1 | $0 (2022) |
| Paratek Pharmaceuticals, Inc. | $21.55 | 1 | $0 (2024) |
| Allergan Inc. | $17.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.97 | 5 | Smith+Nephew, Inc. ($54.51) |
| 2023 | $40.60 | 2 | Smith+Nephew, Inc. ($40.60) |
| 2022 | $36.69 | 2 | Nevro Corp. ($22.12) |
| 2021 | $82.95 | 5 | Novo Nordisk Inc ($82.95) |
| 2019 | $68.22 | 4 | Janssen Pharmaceuticals, Inc ($68.22) |
| 2018 | $98.01 | 6 | Janssen Pharmaceuticals, Inc ($85.83) |
| 2017 | $289.88 | 16 | Janssen Pharmaceuticals, Inc ($108.27) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: FOOT AND ANKLE | ||||||
| 09/09/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: FOOT AND ANKLE | ||||||
| 08/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: ANTIBIOTIC | ||||||
| 04/29/2024 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Extra Cellular Matrix | ||||||
| 02/12/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), STRAVIX PL, OASIS | Food and Beverage | In-kind items and services | $38.47 | General |
| Category: Other Advanced Wound Management | ||||||
| 10/18/2023 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Other Advanced Wound Management | ||||||
| 03/31/2023 | Smith+Nephew, Inc. | GRAFIX (Medical Supply) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Other Advanced Wound Management | ||||||
| 07/05/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/09/2022 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Recon-Skin and Wound | ||||||
| 06/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 05/07/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 05/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 03/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 02/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Diabetes | ||||||
| 06/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 721 | 1,190 | $156,781 | $64,027 |
| 2022 | 13 | 559 | 1,177 | $118,075 | $62,684 |
| 2021 | 9 | 345 | 759 | $78,736 | $42,210 |
| 2020 | 12 | 405 | 795 | $78,386 | $39,879 |
Total Patients
2,030
Total Services
3,921
Medicare Billing
$208,800
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 358 | $52,716 | $22,634 | 42.9% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 147 | 288 | $25,955 | $9,768 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 82 | 127 | $14,446 | $5,471 | 37.9% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2023 | 48 | 57 | $10,604 | $5,102 | 48.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $9,818 | $3,633 | 37.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $8,871 | $3,569 | 40.2% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 29 | 50 | $6,629 | $2,993 | 45.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 66 | $6,691 | $2,695 | 40.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 27 | 30 | $5,869 | $2,053 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 18 | $3,808 | $1,649 | 43.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 23 | $3,768 | $1,492 | 39.6% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 37 | 57 | $3,134 | $1,215 | 38.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 14 | 20 | $2,678 | $1,153 | 43.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,794 | $601.50 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 325 | $38,610 | $22,698 | 58.8% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 74 | 245 | $19,600 | $8,451 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 75 | 75 | $11,150 | $5,995 | 53.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 44 | $12,900 | $4,939 | 38.3% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2022 | 32 | 48 | $6,980 | $4,753 | 68.1% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 24 | 68 | $6,800 | $4,621 | 68.0% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 48 | 145 | $7,250 | $3,836 | 52.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 42 | 70 | $6,370 | $3,131 | 49.1% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 11 | 27 | $2,265 | $1,520 | 67.1% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2022 | 14 | 48 | $1,531 | $908.15 | 59.3% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 15 | 18 | $2,274 | $856.14 | 37.6% |
About Dr. Frank Macri, DPM
Dr. Frank Macri, DPM is a Podiatrist healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093708828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Macri, DPM has received a total of $734.32 in payments from pharmaceutical and medical device companies, with $117.97 received in 2024. These payments were reported across 40 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($734.32).
As a Medicare-enrolled provider, Macri has provided services to 2,030 Medicare beneficiaries, totaling 3,921 services with total Medicare billing of $208,800. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Location Bala Cynwyd, PA
- Active Since 08/26/2005
- Last Updated 05/05/2021
- Taxonomy Code 213E00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093708828
Products in Payments
- XARELTO (Drug) $220.81
- Ozempic (Drug) $82.95
- GRAFIX PL (Medical Supply) $54.38
- ENTRESTO (Drug) $45.27
- LAPIPLASTY SYSTEM (Device) $41.91
- INVOKANA (Drug) $41.51
- Prolia (Biological) $41.01
- UTIBRON (Drug) $30.51
- GRAFIX (Medical Supply) $24.69
- Omnia (Device) $22.12
- NUZYRA (Drug) $21.55
- Repatha (Biological) $18.47
- VIBERZI (Drug) $17.71
- DUZALLO (Drug) $16.91
- STRAVIX PL (Medical Supply) $16.04
- Integra (Device) $14.57
- LYRICA (Drug) $12.18
- BELSOMRA (Drug) $11.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.